GCK and MODY: The identification of a GCK mutation in subjects whose clinical phenotype is suggestive of MODY usually distinguishes patients with a benign prognosis (GCK MODY) from those with a severe hyperglycemia (HNF1A MODY and other MODY forms) because the diagnosis cannot be always made on clinical grounds alone.